The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The CPTAC Data Portal: A Resource for Cancer Proteomics Research
Abstract
The Clinical Proteomic Tumor Analysis Consortium (CPTAC), under the auspices of the National Cancer Institute's Office of Cancer Clinical Proteomics Research, is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of proteomic technologies and workflows to clinical tumor samples with characterized genomic and transcript profiles. The consortium analyzes cancer biospecimens using mass spectrometry, identifying and quantifying the constituent proteins and characterizing each tumor sample's proteome. Mass spectrometry enables highly specific identification of proteins and their isoforms, accurate relative quantitation of protein abundance in contrasting biospecimens, and localization of post-translational protein modifications, such as phosphorylation, on a protein's sequence. The combination of proteomics, transcriptomics, and genomics data from the same clinical tumor samples provides an unprecedented opportunity for tumor proteogenomics. The CPTAC Data Portal is the centralized data repository for the dissemination of proteomic data collected by Proteome Characterization Centers (PCCs) in the consortium. The portal currently hosts 6.3 TB of data and includes proteomic investigations of breast, colorectal, and ovarian tumor tissues from The Cancer Genome Atlas (TCGA). The data collected by the consortium is made freely available to the public through the data portal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037
Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M., Ham, A.-J. L., Bunk, D. M., Kilpatrick, L. E., Billheimer, D. D., Blackman, R. K., Cardasis, H. L., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr9006365 · Cited by 551
Reiter, L., Claassen, M., Schrimpf, S. P., Jovanovic, M., Schmidt, A., Buhmann, J. M., Hengartner, M. O., & Aebersold, R. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900317-mcp200 · Cited by 312
Cited by
UniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372
Self-citationLinkedOmics: analyzing multi-omics data within and across 32 cancer types
Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1090 · Cited by 2,312
Algorithmic fairness in artificial intelligence for medicine and healthcare
Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., Sahai, S., & Mahmood, F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01056-8 · Cited by 750
Proteogenomic Characterization of Endometrial Carcinoma
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485
Self-citationAdvances in medical image analysis with vision Transformers: A comprehensive review
Azad, R., Kazerouni, A., Heidari, M., Aghdam, E. K., Molaei, A., Jia, Y., Jose, A., Roy, R., & Merhof, D. (2024) · Medical Image Analysis · doi:10.1016/j.media.2023.103000 · Cited by 485
Deep learning based multimodal biomedical data fusion: an overview and comparative review
Duan, J., Xiong, J., Li, Y., & Ding, W. (2024) · Information Fusion · doi:10.1016/j.inffus.2024.102536 · Cited by 284
Wagner, S. J., Reisenbüchler, D., West, N. P., Niehues, J. M., Zhu, J., Foersch, S., Veldhuizen, G. P., Quirke, P., Grabsch, H. I., van den Brandt, P. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.08.002 · Cited by 275
A Graph-Transformer for Whole Slide Image Classification
Zheng, Y., Gindra, R. H., Green, E. J., Burks, E. J., Betke, M., Beane, J. E., & Kolachalama, V. B. (2022) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3176598 · Cited by 255
A multimodal whole-slide foundation model for pathology
Ding, T., Wagner, S. J., Song, A. H., Chen, R. J., Lu, M. Y., Zhang, A., Vaidya, A. J., Jaume, G., Shaban, M., Kim, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03982-3 · Cited by 171
“…we perform cross-validation on one cohort, for example, from The Cancer Genome Atlas (TCGA) 96,97 , and use the remaining cohorts, for example, from Clinical Proteomic Tumor Analysis Consortium (CPTAC) 98,99 or Dartmouth-Hitchcock Medical Center (DHMC) 100,101 , as an external test cohort.”
InfluentialDolezal, J. M., Srisuwananukorn, A., Karpeyev, D., Ramesh, S., Kochanny, S., Cody, B., Mansfield, A. S., Rakshit, S., Bansal, R., Bois, M. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34025-x · Cited by 147
Fast and scalable search of whole-slide images via self-supervised deep learning
Chen, C., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Schaumberg, A. J., & Mahmood, F. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00929-8 · Cited by 130
Machine learning methods for histopathological image analysis: updates in 2024
Komura, D., Ochi, M., & Ishikawa, S. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.12.033 · Cited by 76
A Multimodal Knowledge-enhanced Whole-slide Pathology Foundation Model
Xu, Y., Wang, Y., Zhou, F., Ma, J., Jin, C., Yang, S., Li, J., Zhang, Z., Zhao, C., Zhou, H., et al. (2024) · arXiv · doi:10.48550/arxiv.2407.15362 · Cited by 60
Zheng, Y., Conrad, R. D., Green, E. J., Burks, E. J., Betke, M., Beane, J. E., & Kolachalama, V. B. (2024) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2024.3386108 · Cited by 44
“We obtained WSIs, bulk gene expression data, demographic, and clinical (including overall survival) data on subjects with LUAD or LUSC from The Cancer Genome Atlas (TCGA) [4], the Clinical Proteomic Tumor Analysis Consortium (CPTAC) [9], and the National Lung Screening Trial (NLST) [10] (Table.”
MethodFedorov, A., Longabaugh, W. J. R., Pot, D., Clunie, D. A., Pieper, S. D., Gibbs, D. L., Bridge, C., Herrmann, M. D., Homeyer, A., Lewis, R., et al. (2023) · Radiographics · doi:10.1148/rg.230180 · Cited by 35
Extendable and explainable deep learning for pan-cancer radiogenomics research
Liu, Q., & Hu, P. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.102111 · Cited by 27
Corry, S. M., McCorry, A. M., Lannagan, T. R., Leonard, N. A., Fisher, N. C., Byrne, R. M., Tsantoulis, P., Cortes-Lavaud, X., Amirkhah, R., Redmond, K. L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326183 · Cited by 18
Lian, Q., Ma, C., Wang, X., Wang, J., Zeng, J., Zhang, J., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1668627 · Cited by 10
A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance
Karunaraj, P., Scheele, R., Wells, M. L., Rathod, R., Gokulu, I. S., Abrahamson, S. R., Taylor, L., Chowdhury, L., Kazmi, A., Song, W., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70060-8 · Cited by 7
Image Analysis: Understanding and Mitigating Batch Effects in Histopathology
Gindra, R. H., Boushehri, S. S., Wagner, S. J., Tran, M., Winter, D. J. E., Schnabel, J. A., Saur, D., Marr, C., & Peng, T. (2025) · Trillium Pathology · doi:10.47184/tp.2025.01.03 · Cited by 2
Metadata
- Authors
- Edwards, N. J., Oberti, M., Thangudu, R. R., Cai, S., McGarvey, P. B., Jacob, S., Madhavan, S., & Ketchum, K. A.
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-05-04
- Volume
- 14
- Issue
- 6
- Pages
- 2707-2713
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2329674354
- Cited by
- 558
- References
- 5
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
